Skip to main content

Advertisement

SpringerLink
Log in

Clinical significance of TP53 mutation in myeloma

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Vousden KH, Lu X . Live or let die: the cell's response to p53. Nat Rev Cancer 2002; 2: 594–604.

    Article  CAS  PubMed  Google Scholar 

  2. Fonseca R, Barlogie B, Bataille R, Bastard C, Bergsagel PL, Chesi M et al. Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res 2004; 64: 1546–1558.

    Article  CAS  PubMed  Google Scholar 

  3. Fonseca R, Blood E, Rue M, Harrington D, Oken MM, Kyle RA et al. Clinical and biologic implications of recurrent genomic aberrations in myeloma. Blood 2003; 101: 4569–4575.

    Article  CAS  PubMed  Google Scholar 

  4. Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Blade J et al. International staging system for multiple myeloma. J Clin Oncol 2005; 23: 3412–3420.

    Article  PubMed  Google Scholar 

  5. Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M et al. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 1996; 274: 373–376.

    Article  CAS  PubMed  Google Scholar 

  6. Zhang WW, Fang X, Mazur W, French BA, Georges RN, Roth JA . High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther 1994; 1: 5–13.

    PubMed  Google Scholar 

  7. Kirn D, Hermiston T, McCormick F . ONYX-015: clinical data are encouraging. Nat Med 1998; 4: 1341–1342.

    Article  CAS  PubMed  Google Scholar 

  8. Tolcher AW, Hao D, de Bono J, Miller A, Patnaik A, Hammond LA et al. Phase I, pharmacokinetic, and pharmacodynamic study of intravenously administered Ad5CMV-p53, an adenoviral vector containing the wild-type p53 gene, in patients with advanced cancer. J Clin Oncol 2006; 24: 2052–2058.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology-Oncology, Mayo Clinic Scottsdale, Scottsdale, AZ, USA

    W J Chng, S Van Wier & R Fonseca

  2. Division of Hematology, Mayo Clinic Rochester, Rochester, MN, USA

    T Price-Troska, N Gonzalez-Paz, K Henderson, P Greipp & S V Rajkumar

  3. Eastern Cooperative Oncology Group Statistical Center, Dana Farber Cancer Institute, Boston, MA, USA

    S Jacobus & E Blood

  4. Department of Oncology, North Memorial Cancer Center, Minneapolis, MN, USA

    M Oken

  5. Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA. E-mail: fonseca.rafael@mayo.edu,

    B Van Ness

Authors
  1. W J Chng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T Price-Troska
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N Gonzalez-Paz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S Van Wier
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S Jacobus
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E Blood
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. K Henderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M Oken
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. B Van Ness
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. P Greipp
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. S V Rajkumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. R Fonseca
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chng, W., Price-Troska, T., Gonzalez-Paz, N. et al. Clinical significance of TP53 mutation in myeloma. Leukemia 21, 582–584 (2007). https://doi.org/10.1038/sj.leu.2404524

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404524

  • Springer Nature Limited

This article is cited by

Search

Navigation